Open Beta
TREN
MetriLume
TREN

US marketsINBS

SEC-sourced researchBeta

INBS

INTELLIGENT BIO SOLUTIONS INC.

Company comparison ↗

Data passport

CIK
0001725430
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Sep 23, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: June 2025: 3,052,532.0000 USD; June 2026: 4,215,175.0000 USD4.2M USD0 USD0June 2025June 2026
INBS · Exact amounts and source periods · USD
Period endRevenueFiling date
June 20253,052,532.0000Aug 19, 2026
June 20264,215,175.0000Aug 19, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
June 20264,215,175.0000-12,430,975.0000-11,927,222.000011,941,836.00006,651,010.0000Aug 19, 2026
June 20253,052,532.0000-10,568,733.0000-9,677,313.00008,249,786.00005,435,962.0000Aug 19, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$4.22MJune 2026Aug 19, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$3.05MJune 2025Aug 19, 202610-K
Net incomeNetIncomeLoss-$12.43MJune 2026Aug 19, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$11.93MJune 2026Aug 19, 202610-K
Total assetsAssets$11.94MJune 2026Aug 19, 202610-K
Total liabilitiesLiabilities$6.65MJune 2026Aug 19, 202610-K

New filings

Explore methodology ↗